ONCO
Onconetix·NASDAQ
--
--(--)
--
--(--)
ONCO fundamentals
Onconetix (ONCO) expects to report earnings on Nov 17, 2023, with estimated revenue of 0 (YoY --), and EPS at -3.23K (YoY +29.63%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-3.23K
+29.63%
Report date
Nov 17, 2023
EPS
Actual | -4590 | -3400 | -3060 | -3060 | |||
Forecast | -4505 | -3485 | -2040 | -3230 | |||
Surprise | 0.00% | 0.00% | 0.00% | +24.53% | +12.20% | -50.00% | 0.00% |
Revenue
Actual | -- | -- | 0 | 0 | -- | -- | -- |
Forecast | -- | -- | -- | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Onconetix beat or miss consensus estimates last quarter?What does Onconetix do and what are its main business segments?What were the key takeaways from Onconetix’s earnings call?What factors drove the changes in Onconetix's revenue and profit?What is the market's earnings forecast for Onconetix next quarter?What guidance did Onconetix's management provide for the next earnings period?What were the key takeaways from Onconetix's earnings call?What is Onconetix's gross profit margin?
